Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer

Michael Chuong, Springett GM, Weber JM, Klapman J, Vignesh S, Hodul PJ, Malafa MP, Leuthold S, Hoffe SE, Shridhar R

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Radiation Oncology
Volume1
StatePublished - 2012

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Radiation Medicine

Cite this